24.17

3.36% -0.8413

Beam Therapeutics Inc (BEAM)

Overview News Price History Option Chain Financials Why BEAM Down? Discussions Forecast

Beam Therapeutics Inc stock is traded at $24.17, with a volume of 1.90M. It is down -3.36% in the last 24 hours and down -6.14% over the past month. Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Previous Close:

$25.01

Open:

$24.67

24h Volume:

1.90M

Relative Volume:

0.72

Market Cap:

$2.44B

Revenue:

$352.57M

Net Income/Loss:

$-143.01M

P/E Ratio:

-13.35

EPS:

-1.81

Net Cash Flow:

$-153.40M

1W Performance:

-9.58%

1M Performance:

-6.14%

6M Performance:

+19.42%

1Y Performance:

+5.41%

1-Day Range:

$23.04

$25.19

1-Week Range:

$23.04

$26.67

52-Week Range:

$13.53

$35.25

Beam Therapeutics Inc Stock (BEAM) Company Profile

Name

Beam Therapeutics Inc

Sector

Healthcare (1139)

Industry

Biotechnology (635)

Phone

857-327-8775

Address

26 LANDSDOWNE STREET, CAMBRIDGE, MA

Employee

509

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

BEAM's Discussions on Twitter

Compare BEAM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BEAM Beam Therapeutics Inc	24.15	2.53B	352.57M	-143.01M	-153.40M	-1.81
VRTX Vertex Pharmaceuticals Inc	425.08	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	641.99	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	432.26	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	822.85	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	183.78	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-09-25	Initiated	Jefferies	Buy
Mar-28-25	Upgrade	BofA Securities	Neutral → Buy
Mar-10-25	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Jan-29-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Nov-06-24	Upgrade	Leerink Partners	Market Perform → Outperform
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Jul-23-24	Initiated	H.C. Wainwright	Buy
Jan-29-24	Upgrade	JP Morgan	Neutral → Overweight
Dec-15-23	Downgrade	BofA Securities	Buy → Neutral
Dec-08-23	Downgrade	Jefferies	Buy → Hold
Oct-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Oct-20-23	Downgrade	Leerink Partners	Outperform → Market Perform
Mar-21-23	Initiated	Bernstein	Mkt Perform
Feb-01-23	Initiated	Cantor Fitzgerald	Overweight
Dec-20-22	Upgrade	BMO Capital Markets	Market Perform → Outperform
Dec-13-22	Initiated	Citigroup	Buy
Jun-17-22	Initiated	BMO Capital Markets	Market Perform
Apr-28-22	Initiated	Credit Suisse	Neutral
Jan-05-22	Initiated	Guggenheim	Buy
Oct-19-21	Initiated	SVB Leerink	Outperform
Sep-24-21	Resumed	Stifel	Buy
Sep-10-21	Initiated	BofA Securities	Buy
May-11-21	Initiated	Redburn	Buy
May-04-21	Initiated	RBC Capital Mkts	Sector Perform
Mar-01-21	Downgrade	Barclays	Overweight → Equal Weight
Feb-16-21	Initiated	Wells Fargo	Overweight
Jan-29-21	Downgrade	JP Morgan	Overweight → Neutral
Jan-06-21	Initiated	Stifel	Hold
Aug-05-20	Initiated	William Blair	Outperform
Mar-02-20	Initiated	Barclays	Overweight
Mar-02-20	Initiated	JP Morgan	Overweight
Mar-02-20	Initiated	Jefferies	Buy
Mar-02-20	Initiated	Wedbush	Outperform

View All

Beam Therapeutics Inc Stock (BEAM) Latest News

09:35 AM

Beam to present updated data on sickle cell gene therapy at ASH meeting - Investing.com

09:35 AM

09:00 AM

ASH 2025: Beam Therapeutics (NASDAQ: BEAM) to share updated BEAM-101 sickle cell data - Stock Titan

09:00 AM

08:22 AM

Why retail investors favor Beam Therapeutics Inc. stockTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com

08:22 AM

06:13 AM

Institutional scanner results for Beam Therapeutics Inc.Market Rally & Fast Exit Strategy with Risk Control - newser.com

06:13 AM

05:41 AM

AMG National Trust Bank Buys Shares of 17,007 Beam Therapeutics Inc. $BEAM - MarketBeat

05:41 AM

05:15 AM

What is the fair value of Beam Therapeutics Inc. stock nowWeekly Trend Summary & Community Consensus Stock Picks - newser.com

05:15 AM

05:11 AM

How buybacks impact Beam Therapeutics Inc. stock valueQuarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com

05:11 AM

03:22 AM

How Beam Therapeutics Inc. stock compares to market leaders2025 Market Overview & Accurate Buy Signal Alerts - newser.com

03:22 AM

Nov 02, 2025

Real time social sentiment graph for Beam Therapeutics Inc.2025 Market Overview & Expert Curated Trade Ideas - newser.com

Nov 02, 2025

How to monitor Beam Therapeutics Inc. with trend dashboardsStop Loss & High Accuracy Trade Signal Alerts - newser.com

Nov 02, 2025

Published on: 2025-11-02 01:58:11 - newser.com

Nov 02, 2025

Nov 01, 2025

Why Beam Therapeutics Inc. stock is favored by pension fundsQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com

Nov 01, 2025

Will Beam Therapeutics Inc. stock deliver long term returnsPortfolio Profit Report & Weekly Top Performers Watchlists - newser.com

Nov 01, 2025

Should you wait for a breakout in Beam Therapeutics Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 01, 2025

Oct 31, 2025

Will Beam Therapeutics Inc. stock outperform Nasdaq indexInsider Buying & Stepwise Trade Signal Guides - newser.com

Oct 31, 2025

What hedge fund activity signals for Beam Therapeutics Inc. stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com

Oct 31, 2025

Published on: 2025-10-31 03:50:40 - newser.com

Oct 31, 2025

Visualizing Beam Therapeutics Inc. stock with heatmaps2025 Institutional Moves & Daily Chart Pattern Signals - newser.com

Oct 31, 2025

ETFs Investing in Beam Therapeutics Inc. Stocks - TradingView

Oct 31, 2025

Why retail investors pile into Beam Therapeutics Inc. stockTreasury Yields & Real-Time Volume Triggers - newser.com

Oct 31, 2025

Oct 30, 2025